| Primary |
| Sedation |
24.0% |
| Anaesthesia |
20.2% |
| Drug Use For Unknown Indication |
11.4% |
| Product Used For Unknown Indication |
7.6% |
| Sedative Therapy |
4.2% |
| Epilepsy |
3.8% |
| Skin Test Negative |
3.8% |
| General Anaesthesia |
3.0% |
| Completed Suicide |
2.3% |
| Convulsion |
2.3% |
| Endotracheal Intubation |
2.3% |
| Induction Of Anaesthesia |
2.3% |
| Anaesthesia Procedure |
1.9% |
| Infection Prophylaxis |
1.9% |
| Analgesia |
1.5% |
| Aortic Bypass |
1.5% |
| Convulsion Neonatal |
1.5% |
| Dyspnoea |
1.5% |
| Off Label Use |
1.5% |
| Premedication |
1.5% |
|
| Medication Error |
12.7% |
| Drug Ineffective |
9.5% |
| Tremor |
9.5% |
| Anaphylactic Reaction |
7.9% |
| Completed Suicide |
6.3% |
| Bradycardia |
4.8% |
| Sedation |
4.8% |
| Unresponsive To Stimuli |
4.8% |
| Urinary Retention |
4.8% |
| Delayed Recovery From Anaesthesia |
3.2% |
| Disseminated Intravascular Coagulation |
3.2% |
| Drug Exposure During Pregnancy |
3.2% |
| Dyskinesia |
3.2% |
| No Therapeutic Response |
3.2% |
| Psychomotor Hyperactivity |
3.2% |
| Restlessness |
3.2% |
| Somatoform Disorder |
3.2% |
| Suicidal Behaviour |
3.2% |
| Swelling Face |
3.2% |
| Tracheomalacia |
3.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
32.6% |
| Product Used For Unknown Indication |
13.2% |
| Anaesthesia |
10.2% |
| Sedation |
6.6% |
| General Anaesthesia |
5.2% |
| Induction Of Anaesthesia |
4.9% |
| Insomnia |
3.3% |
| Sedative Therapy |
3.2% |
| Hypertension |
2.8% |
| Rhabdomyosarcoma |
2.6% |
| Infection Prophylaxis |
2.3% |
| Scoliosis Surgery |
2.3% |
| Pain |
2.0% |
| Pyrexia |
1.9% |
| Anaesthesia Procedure |
1.4% |
| Agitation |
1.3% |
| Thrombosis Prophylaxis |
1.3% |
| Nausea |
1.1% |
| Convulsion |
0.9% |
| Percutaneous Coronary Intervention |
0.9% |
|
| Hypotension |
10.0% |
| Cardiac Arrest |
8.9% |
| Respiratory Arrest |
6.7% |
| Sinus Tachycardia |
6.7% |
| Urine Output Decreased |
6.7% |
| Urticaria |
6.7% |
| Toxic Epidermal Necrolysis |
5.6% |
| Medication Error |
4.4% |
| Mucosal Inflammation |
4.4% |
| Overdose |
4.4% |
| Skin Discolouration |
4.4% |
| Wheezing |
4.4% |
| Cytolytic Hepatitis |
3.3% |
| Drug Ineffective |
3.3% |
| Hepatitis Acute |
3.3% |
| Hypoxia |
3.3% |
| Partial Seizures |
3.3% |
| Sedation |
3.3% |
| Shock |
3.3% |
| Somnolence |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.4% |
| Drug Use For Unknown Indication |
18.3% |
| Prophylaxis |
10.8% |
| Anaesthesia |
9.4% |
| Pain |
4.7% |
| Sedation |
4.2% |
| Hypertension |
4.0% |
| Metastases To Bone |
3.6% |
| Induction Of Anaesthesia |
3.5% |
| Constipation |
2.6% |
| Analgesic Effect |
2.3% |
| Infection |
2.2% |
| Ill-defined Disorder |
2.1% |
| Cardiomyopathy |
1.9% |
| Nausea |
1.6% |
| Sepsis |
1.4% |
| Hiv Infection |
1.3% |
| Wisdom Teeth Removal |
1.3% |
| Antibiotic Prophylaxis |
1.2% |
| Acute Myeloid Leukaemia |
1.1% |
|
| Urinary Tract Infection |
8.5% |
| Renal Failure |
7.4% |
| Vomiting |
7.4% |
| White Blood Cell Count |
6.4% |
| Convulsion |
5.3% |
| Hypotension |
5.3% |
| Respiratory Failure |
5.3% |
| Sepsis |
5.3% |
| Ventricular Tachycardia |
5.3% |
| Hyperbilirubinaemia |
4.3% |
| Liver Disorder |
4.3% |
| Nausea |
4.3% |
| Renal Failure Acute |
4.3% |
| Renal Tubular Acidosis |
4.3% |
| Renal Tubular Disorder |
4.3% |
| Sudden Death |
4.3% |
| Urosepsis |
4.3% |
| Coagulation Time Prolonged |
3.2% |
| Hepatitis |
3.2% |
| Meniscus Lesion |
3.2% |
|
| Interacting |
| Restlessness |
27.3% |
| Depression |
18.2% |
| Premedication |
18.2% |
| Abdominal Pain |
9.1% |
| Dyspnoea |
9.1% |
| Hallucination |
9.1% |
| Nausea |
9.1% |
|
| Drug Interaction |
66.7% |
| Oxygen Saturation Decreased |
33.3% |
|
